drugset / Trial / NCT00002219

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

NCT00002219

Phase 2 Unknown 36 enrolled Gilead Sciences
Treatment

Summary

The purpose of this study is to see if it is safe and effective to give adefovir (a new anti-HIV drug) plus nelfinavir to HIV-infected children who are already receiving other anti-HIV medications.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir Unknown
Subject Nelfinavir Other / unclassified
Background L-carnitine Other / unclassified